THE HEALTHCARE NEWS DIARIES

Britain’s drug regulator accepted the Alzheimer’s drug Kisunla on Wednesday, but The federal government gained’t be purchasing it soon after an independent watchdog agency reported the procedure isn’t worth the Price tag to taxpayersWhat wellbeing industry experts think of the increasing copyright “microdosing” development that statemen